Funda Başyiğit, Havva Tuğba Gürsoy, Özlem Özcan Çelebi, Kevser Gülcihan Balcı, Özgül Uçar Elalmış, Kerem Özbek, Özge Çakmak Karaaslan, Mehmet Ileri, Telat Keleş, Sinan Aydoğdu
{"title":"CHA2DS2-VASc评分与主动脉瓣硬化的关系","authors":"Funda Başyiğit, Havva Tuğba Gürsoy, Özlem Özcan Çelebi, Kevser Gülcihan Balcı, Özgül Uçar Elalmış, Kerem Özbek, Özge Çakmak Karaaslan, Mehmet Ileri, Telat Keleş, Sinan Aydoğdu","doi":"10.5830/CVJA-2023-022","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Antithrombotic therapy in atrial fibrillation is generally managed with the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. Aortic valve sclerosis (AVS) is a focal thickening of the aortic valve without a restriction of motion. AVS is related to several cardiovascular risk factors. Our study was performed to evaluate whether the presence of AVS was associated with the CHA<sub>2</sub>DS<sub>2</sub>-VASc score.</p><p><strong>Methods: </strong>This cross-sectional, observational study comprised 411 patients with AVS grades 1-3 [AVS (+)] and 102 patients with AVS grade 0 [AVS (-)]. We compared CHA<sub>2</sub>DS<sub>2</sub>-VASc scores between the AVS (+) and AVS (-) groups.</p><p><strong>Results: </strong>We determined that the AVS (+) group had a higher CHA<sub>2</sub>DS<sub>2</sub>-VASc score than the AVS (-) group [3 (0-8) vs 1 (0-4), <i>p</i> < 0.001) ].</p><p><strong>Conclusions: </strong>In our study, the CHA<sub>2</sub>DS<sub>2</sub>-VASc score was found to be higher in patients with AVS than in those without AVS. AVS may predict cardiovascular risk in the general population.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":"34 ","pages":"1-6"},"PeriodicalIF":0.7000,"publicationDate":"2023-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The association between CHA<sub>2</sub>DS<sub>2</sub>-VASc score and aortic valve sclerosis.\",\"authors\":\"Funda Başyiğit, Havva Tuğba Gürsoy, Özlem Özcan Çelebi, Kevser Gülcihan Balcı, Özgül Uçar Elalmış, Kerem Özbek, Özge Çakmak Karaaslan, Mehmet Ileri, Telat Keleş, Sinan Aydoğdu\",\"doi\":\"10.5830/CVJA-2023-022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Antithrombotic therapy in atrial fibrillation is generally managed with the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. Aortic valve sclerosis (AVS) is a focal thickening of the aortic valve without a restriction of motion. AVS is related to several cardiovascular risk factors. Our study was performed to evaluate whether the presence of AVS was associated with the CHA<sub>2</sub>DS<sub>2</sub>-VASc score.</p><p><strong>Methods: </strong>This cross-sectional, observational study comprised 411 patients with AVS grades 1-3 [AVS (+)] and 102 patients with AVS grade 0 [AVS (-)]. We compared CHA<sub>2</sub>DS<sub>2</sub>-VASc scores between the AVS (+) and AVS (-) groups.</p><p><strong>Results: </strong>We determined that the AVS (+) group had a higher CHA<sub>2</sub>DS<sub>2</sub>-VASc score than the AVS (-) group [3 (0-8) vs 1 (0-4), <i>p</i> < 0.001) ].</p><p><strong>Conclusions: </strong>In our study, the CHA<sub>2</sub>DS<sub>2</sub>-VASc score was found to be higher in patients with AVS than in those without AVS. AVS may predict cardiovascular risk in the general population.</p>\",\"PeriodicalId\":9434,\"journal\":{\"name\":\"Cardiovascular Journal of Africa\",\"volume\":\"34 \",\"pages\":\"1-6\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2023-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Journal of Africa\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5830/CVJA-2023-022\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Journal of Africa","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5830/CVJA-2023-022","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:房颤的抗血栓治疗通常采用CHA2DS2-VASc评分。主动脉瓣硬化(AVS)是主动脉瓣的局灶性增厚，不限制运动。AVS与几种心血管危险因素有关。我们的研究是为了评估AVS的存在是否与CHA2DS2-VASc评分相关。方法:本横断面观察性研究纳入411例AVS分级为1-3级的患者[AVS(+)]和102例AVS分级为0级的患者[AVS(-)]。我们比较了AVS(+)组和AVS(-)组的CHA2DS2-VASc评分。结果:我们确定AVS(+)组的CHA2DS2-VASc评分高于AVS(-)组[3 (0-8)vs 1 (0-4)， p < 0.001]。结论:在我们的研究中，发现AVS患者的CHA2DS2-VASc评分高于无AVS患者。AVS可以预测一般人群的心血管风险。
The association between CHA2DS2-VASc score and aortic valve sclerosis.
Background: Antithrombotic therapy in atrial fibrillation is generally managed with the CHA2DS2-VASc score. Aortic valve sclerosis (AVS) is a focal thickening of the aortic valve without a restriction of motion. AVS is related to several cardiovascular risk factors. Our study was performed to evaluate whether the presence of AVS was associated with the CHA2DS2-VASc score.
Methods: This cross-sectional, observational study comprised 411 patients with AVS grades 1-3 [AVS (+)] and 102 patients with AVS grade 0 [AVS (-)]. We compared CHA2DS2-VASc scores between the AVS (+) and AVS (-) groups.
Results: We determined that the AVS (+) group had a higher CHA2DS2-VASc score than the AVS (-) group [3 (0-8) vs 1 (0-4), p < 0.001) ].
Conclusions: In our study, the CHA2DS2-VASc score was found to be higher in patients with AVS than in those without AVS. AVS may predict cardiovascular risk in the general population.
期刊介绍：
The Cardiovascular Journal of Africa (CVJA) is an international peer-reviewed journal that keeps cardiologists up to date with advances in the diagnosis and treatment of cardiovascular disease. Topics covered include coronary disease, electrophysiology, valve disease, imaging techniques, congenital heart disease (fetal, paediatric and adult), heart failure, surgery, and basic science.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
